[Natalizumab].
Taéron
Corinne
C
corinne.taeron@gmail.com
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D056486:Chemical and Drug Induced Liver Injury; D003142:Communication; D004342:Drug Hypersensitivity / Q000209:etiology; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D009369:Neoplasms / Q000139:chemically induced; D024802:Nurse's Role / Q000523:psychology; D009894:Opportunistic Infections / Q000139:chemically induced; D010353:Patient Education as Topic; D018579:Patient Selection
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab